Imago BioSciences

Imago Bio Sciences

Biotechnology, South San Francisco CA Us, Redwood City, California, 94080, United States, 11-50 Employees

imagobio.com

  • twitter
  • LinkedIn

phone no Phone Number: 41********

Who is IMAGO BIOSCIENCES

Our scientific efforts are aimed at developing drugs that improve the management of proliferative diseases of the bone marrow. Our clinical focus is on acute myeloid leukemia, myelodyspla...

Read More

map
  • South San Francisco CA 94080 Us, Redwood City, California, 94080, United States Headquarters: South San Francisco CA 94080 Us, Redwood City, California, 94080, United States
  • 2012 Date Founded: 2012
  • 11-50 Employees: 11-50
  • dollar-icon Revenue: $5 Million to $10 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 2836 | NAICS Code: 541714 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from IMAGO BIOSCIENCES

Imago BioSciences Org Chart and Mapping

Employees

Lisa Tremmel

Sr. Clinical Scientist

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Imago BioSciences

Answer: Imago BioSciences's headquarters are located at South San Francisco CA Us, Redwood City, California, 94080, United States

Answer: Imago BioSciences's phone number is 41********

Answer: Imago BioSciences's official website is https://imagobio.com

Answer: Imago BioSciences's revenue is $5 Million to $10 Million

Answer: Imago BioSciences's SIC: 2836

Answer: Imago BioSciences's NAICS: 541714

Answer: Imago BioSciences has 11-50 employees

Answer: Imago BioSciences is in Biotechnology

Answer: Imago BioSciences contact info: Phone number: 41******** Website: https://imagobio.com

Answer: Our scientific efforts are aimed at developing drugs that improve the management of proliferative diseases of the bone marrow. Our clinical focus is on acute myeloid leukemia, myelodysplastic syndrome, polycythemia vera, myelofibrosis and essential thrombocythemia. These diseases share several features. They are diseases caused by acquired mutations in blood stem cells. To varying degrees, these mutations drive excessive growth of bone marrow cells, as well as alter their function. For example, myelofibrosis can be viewed as a chronic inflammatory disorder in which inflammatory cytokines and growth factors cause bone marrow cells to alter the architecture of and ultimately destroy the bone marrow. Imago BioSciences has developed inhibitors of the enzyme lysine-specific demethylase 1 (LSD1). This enzyme plays a critical role in regulating the growth and development of bone marrow cells. Our first clinical inhibitor of LSD1, bomedemstat (or IMG-7289) is being studied in patients with acute myeloid leukemia, myelodysplastic syndrome, and myeloproliferative neoplasms including myelofibrosis. Future clinical studies are planned for other related diseases.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access